Cumberland Pharmaceuticals (CPIX) Cost of Revenue (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Cost of Revenue of $1.9 million for Q1 2026, down 13.72% sequentially from $2.2 million in Q4 2025, and up 35.64% YoY from $1.4 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Cost of Revenue (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Cost of Revenue for 17 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Cost of Revenue rose 35.64% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (up 11.49% YoY) and the FY2025 annual result came in at $6.7 million, up 1.23% from the prior year.
- Cost of Revenue eased to $1.9 million in Q1 2026 per CPIX's latest filing, from $2.2 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $2.7 million in Q4 2022 and troughed at $988760.0 in Q3 2025.
- A 5-year average of $1.8 million and a median of $1.8 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue jumped 67.5% in 2022, then plunged 43.48% in 2023.
- Over 5 years, Cost of Revenue stood at $2.7 million in 2022, then slumped by 42.27% to $1.5 million in 2023, then increased by 29.18% to $2.0 million in 2024, then increased by 13.4% to $2.2 million in 2025, then slipped by 13.72% to $1.9 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $1.9 million, $2.2 million, and $988760.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.61 Mn | 113.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 988,760.00 |
| Sep 30, 2025 | 988,760.00 |
| Jun 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Dec 31, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Dec 31, 2023 | 1.53 Mn |